University of California San Francisco

Give to UCSF
Advanced
1321 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

Will Cell Therapy Become a 'Third Pillar' of Medicine?

Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers who have outlined their vision of cell-based therapeutics as a “third pillar of medicine."

Placeholder image

National Study to Examine Risks, Benefits in Emergent Whole Genome Sequencing

<p>Improving technologies are rapidly cutting the cost of whole genome sequencing, a process that reveals the complete library of a patient’s genetic information. UCSF School of Pharmacy's Kathryn Phillips, PhD, will lead the first national study to analyze how physicians and patients evaluate the benefits and risks posed by this profusion of information.</p>

Placeholder image